| Title: |
CK2 Inhibitors Targeting Inside and Outside the Catalytic Box |
| Authors: |
Day-Riley, Sophie; West, Rebekah M; Brear, Paul D; Hyvönen, Marko; Spring, David R |
| Publisher Information: |
MDPI; //doi.org/10.3390/kinasesphosphatases2020007 |
| Publication Year: |
2024 |
| Collection: |
Apollo - University of Cambridge Repository |
| Subject Terms: |
31 Biological Sciences; 3404 Medicinal and Biomolecular Chemistry; 34 Chemical Sciences; Cancer; 5.1 Pharmaceuticals |
| Description: |
Peer reviewed: True ; Publication status: Published ; Funder: AstraZeneca (AZ) ; Funder: EPSRC ; Funder: BBSRC ; Funder: MRC ; Funder: Cystic Fibrosis Trust UK ; CK2 is a protein kinase that plays an important role in numerous cellular pathways involved in cell growth, differentiation, proliferation, and death. Consequently, upregulation of CK2 is implicated in many disease types, in particular cancer. As such, CK2 has gained significant attention as a potential therapeutic target in cancer, and over 40 chemical probes targeting CK2 have been developed in the past decade. In this review, we highlighted several chemical probes that target sites outside the conventional ATP-binding site. These chemical probes belong to different classes of molecules, from small molecules to peptides, and possess different mechanisms of action. Many of the chemical probes discussed in this review could serve as promising new candidates for drugs selectively targeting CK2. |
| Document Type: |
article in journal/newspaper |
| File Description: |
text/xml; application/pdf |
| Language: |
English |
| Relation: |
https://www.repository.cam.ac.uk/handle/1810/366713 |
| Availability: |
https://www.repository.cam.ac.uk/handle/1810/366713 |
| Rights: |
Attribution 4.0 International ; https://creativecommons.org/licenses/by/4.0/ |
| Accession Number: |
edsbas.F44F656B |
| Database: |
BASE |